Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07368907 · ClinicalTrials.gov registry record · NA

Walk On! National Council on Aging Innovation Lab

A NA study, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
192
Enrollment target

NCT07368907: Recruiting NA study, sponsored by Wake Forest University Health Sciences.

NCT07368907 is a NA study that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07368907, a NA study, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target

Study Summary

This is a multi-site, one-arm type-2 hybrid-effectiveness implementation trial. The goal of this clinical trial is to learn if the Walk On! program helps prevent falls in older adults who have trouble moving around or feel socially isolated. Researchers want to know: 1. What are the best ways for organizations to offer the Walk On! program and keep it running for older adults in their community? 2. Does Walk On! help prevent falls in older adults? Older Adult Participants will: 1. Join group walking sessions led by a trained facilitator 2. Meet twice a week for 12 weeks (24 sessions) 3. Take part in simple tests before and after the program to see if there are any changes in older adults' function, confidence in not falling, or loneliness.

Primary Outcome

Number of community-based organizations that deliver of one full 12-week round of Walk On! to a minimum of 8 participants who have not previously participated in the program. Data Source: community-based organization's site attendance records.

Interventions

  • BEHAVIORAL Walk On! Program

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2026-04-06
Est. Completion 2027-05
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What NCT07368907 shows while recruiting

NCT07368907 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Walk On! Program is the first listed.

NCT07368907 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07368907 about?

NCT07368907 is a clinical study titled "Walk On! National Council on Aging Innovation Lab". This is a multi-site, one-arm type-2 hybrid-effectiveness implementation trial. The goal of this clinical trial is to learn if the Walk On! program helps prevent falls in older adults who have trouble moving around or feel socially isolated. Researchers want to know: 1. What are the best ways for o...

What is the current status of trial NCT07368907?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2026-04-06. Estimated completion is 2027-05.

What interventions are being tested in trial NCT07368907?

The interventions under investigation include: Walk On! Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07368907?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07368907's enrollment target sits among peer trials

192 570th of 2000 higher than 1,427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07368907, the US trial registry maintained by the National Library of Medicine. NCT07368907 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.